Piperacillin
As of the edition of 20 October 2026, Piperacillin is a small molecule: marketed, first approved in 1982 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2008
- Kind
- Small molecule
- Brand name
- Pipracil
- First approved
- 1 January 1982 (US)
- Approvals on record
- 20 in 3 regions
- Holder of the most recent approval
- B. Braun Medical; 6 holders in all
- Registered trials
- 60, 8 stopped early
- Disease areas
- Infections; Lungs and airways; Blood and lymph; Cancer; Digestive system; Inherited and neonatal
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 24 | 13 | 3 | 3 |
| Phase 1 | 6 | 4 | 0 | 0 |
| Phase 2 | 5 | 2 | 0 | 3 |
| Phase 3 | 11 | 7 | 2 | 0 |
| Phase 4 | 14 | 8 | 1 | 2 |
| All trials | 60 |